- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
1 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
Abbott India
Market Cap: ₹592.1b
Operates as a pharmaceutical company in India.
500488
₹27,866.30
7D
0.2%
1Y
-18.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹450.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,657.20
7D
4.2%
1Y
-7.3%
Sanofi India
Market Cap: ₹78.0b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,384.80
7D
0.5%
1Y
-37.5%
Hester Biosciences
Market Cap: ₹21.1b
Manufactures and trades in veterinary vaccines and health products in India and internationally.
New
524669
₹2,441.75
7D
-3.4%
1Y
15.2%